Denali Therapeutics Profit Margin 2016-2021 | DNLI
Current and historical gross margin, operating margin and net profit margin for Denali Therapeutics (DNLI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Denali Therapeutics net profit margin as of June 30, 2021 is 15.66%.
|Denali Therapeutics Annual Profit Margins
|Denali Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.